Suchergebnisse - "Lampertico, Pietro"

PubPharm (149)

1

Chronic Hepatitis B Finite Treatment : Similar and Different Concerns With New Drug Classes

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Peters, M. | Yuen, M. | Terrault, N. | +16

2

Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Anolli, M. | Renteria, S. | Degasperi, E. | +7

3

Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B

enthalten in: Gut | 2024

von Testoni, B. | Scholtès, C. | Plissonnier, M. | +11

4

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B

enthalten in: Journal of hepatology | 2024

von Chun, H. | Papatheodoridis, G. | Lee, M. | +23

5

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D : Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Ghany, M. | Buti, M. | Lampertico, P. | +2

6

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1) : a multicentre, double-blind, active-controlled, randomised, phase 2b trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Yuen, M. | Asselah, T. | Jacobson, I. | +116

CommentIn: Lancet Gastroenterol Hepatol. 2023 Sep;8(9):772-773. - PMID 37442151

7

No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta

enthalten in: Journal of hepatology | 2023

von Hollnberger, J. | Liu, Y. | Xu, S. | +22

8

Bulevirtide for patients with compensated chronic hepatitis delta : A review

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Degasperi, E. | Anolli, M. | Lampertico, P.

9

Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Pelusi, S. | Bianco, C. | Colombo, M. | +52

10

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]